Biological and genetic characteristics of HIV infections in Cameroon reveals dual group M and O infections and a correlation between SI-inducing phenotype of the predominant CRF02_AG variant and disease stage

Virology. 2003 Jun 5;310(2):254-66. doi: 10.1016/s0042-6822(03)00167-3.

Abstract

In Yaounde, Cameroon, HIV-1 group-specific V3 serology on 1469 HIV-positive samples collected between 1996 and 2001 revealed that group O infections remained constant around 1% for 6 years. Only one group N sample was identified and 4.3% reacted with group M and O peptides. Although the sensitivity of the group-specific polymerase chain reaction (PCR) in two genomic regions was not optimal, we confirmed, in at least 6 of 49 (12.2%) dual O/M seropositive samples and in 1 of 9 group O samples, dual infection with group O and M viruses (n = 4) or with group O or M virus and an intergroup recombinant virus (n = 3). Partial env (V3-V5) sequences on a subset of 295 samples showed that at least eight subtypes and five circulating recombinant forms (CRFs) of HIV-1 group M co-circulate; more than 60% were CRF02_AG and 11% had discordant subtype/CRF designations between env and gag. Similarly as for subtype B, the proportion of syncytium-inducing strains increased when CD4 counts were low in CRF02_AG-infected patients. The V3-loop charge was significantly lower for non-syncytium-inducing strains than for syncytium-inducing strains but cannot be used as an individual marker to predict phenotype. The two predominant HIV-1 variants in Africa, CRF02_AG and subtype C, thus have different biological characteristics.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD4 Lymphocyte Count
  • Cameroon / epidemiology
  • Cells, Cultured
  • Cohort Studies
  • Genetic Variation
  • Genotype
  • Giant Cells / virology*
  • HIV Core Protein p24 / genetics
  • HIV Seropositivity / epidemiology*
  • HIV Seropositivity / virology
  • HIV-1 / genetics*
  • HIV-1 / immunology
  • HIV-2 / genetics*
  • HIV-2 / immunology
  • Humans
  • Molecular Epidemiology
  • Phenotype
  • RNA, Viral / genetics
  • Recombination, Genetic

Substances

  • HIV Core Protein p24
  • RNA, Viral